These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35410603)

  • 21. Antiviral, immunomodulatory, and neuroprotective effect of lithium.
    Rybakowski JK
    J Integr Neurosci; 2022 Mar; 21(2):68. PubMed ID: 35364656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium affects rat hippocampal electrophysiology and epileptic seizures in a dose dependent manner.
    Jiang G; Pu T; Li Z; Zhang X; Zhou R; Cao X; Yu J; Wang X
    Epilepsy Res; 2018 Oct; 146():112-120. PubMed ID: 30096484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results.
    Bersudsky Y; Shaldubina A; Kozlovsky N; Woodgett JR; Agam G; Belmaker RH
    Behav Pharmacol; 2008 May; 19(3):217-24. PubMed ID: 18469539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Looking at lithium: molecular moods and complex behaviour.
    Beaulieu JM; Caron MG
    Mol Interv; 2008 Oct; 8(5):230-41. PubMed ID: 19015387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medications.
    Gould TD
    Expert Opin Ther Targets; 2006 Jun; 10(3):377-92. PubMed ID: 16706678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
    Gould TD; Manji HK
    Neuropsychopharmacology; 2005 Jul; 30(7):1223-37. PubMed ID: 15827567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential mechanisms of action of lithium in bipolar disorder. Current understanding.
    Malhi GS; Tanious M; Das P; Coulston CM; Berk M
    CNS Drugs; 2013 Feb; 27(2):135-53. PubMed ID: 23371914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding suicide: Focusing on its mechanisms through a lithium lens.
    Malhi GS; Das P; Outhred T; Irwin L; Morris G; Hamilton A; Lynch K; Mannie Z
    J Affect Disord; 2018 Dec; 241():338-347. PubMed ID: 30142593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lithium treatment - the state of the art for 2020.
    Rybakowski J
    Psychiatr Pol; 2020 Dec; 54(6):1047-1066. PubMed ID: 33740796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurotrophic effects of lithium stimulate the reduction of ischemic and neurodegenerative brain damage].
    Pronin AV; Gogoleva IV; Torshin IY; Gromovа OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(2):99-108. PubMed ID: 27166488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae.
    Gold AB; Herrmann N; Lanctôt KL
    Curr Drug Targets; 2011 Feb; 12(2):243-55. PubMed ID: 20863277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does lithium prevent Alzheimer's disease?
    Forlenza OV; de Paula VJ; Machado-Vieira R; Diniz BS; Gattaz WF
    Drugs Aging; 2012 May; 29(5):335-42. PubMed ID: 22500970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders.
    Bauer M; Alda M; Priller J; Young LT;
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S250-4. PubMed ID: 14677087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium, a potential protective drug in Alzheimer's disease.
    Engel T; Goñi-Oliver P; Gómez de Barreda E; Lucas JJ; Hernández F; Avila J
    Neurodegener Dis; 2008; 5(3-4):247-9. PubMed ID: 18322403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial dysfunction in Alzheimer's disease: Therapeutic implications of lithium.
    Singulani MP; De Paula VJR; Forlenza OV
    Neurosci Lett; 2021 Aug; 760():136078. PubMed ID: 34161823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of lithium in neurodegenerative diseases: new registries for old actors].
    Pérez-Martínez DA
    Neurologia; 2009 Apr; 24(3):143-6. PubMed ID: 19418288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correct treatment of mood disorders with lithium].
    Haussmann R; Lewitzka U; Severus E; Bauer M
    Nervenarzt; 2017 Nov; 88(11):1323-1334. PubMed ID: 28980047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Update - Lithium in the Long-Term Treatment of Bipolar Disorders].
    Petzold J; Bauer M; Severus E
    Fortschr Neurol Psychiatr; 2018 Dec; 86(12):745-753. PubMed ID: 30419584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuroprotective actions of lithium].
    Hashimoto R; Fujimaki K; Jeong MR; Senatorov VV; Christ L; Leeds P; Chuang DM; Takeda M
    Seishin Shinkeigaku Zasshi; 2003; 105(1):81-6. PubMed ID: 12701214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.